Factors predicting the use of immunotherapy for patients with advanced melanoma.

被引：0
|
作者：
Joseph, Richard Wayne
Shillington, Alicia
Macahilig, Cynthia
Diede, Scott J.
Dave, Vaidehi
Harshaw, Qing
Liu, Frank Xiaoqing
机构：
[1] Mayo Clin, Jacksonville, FL 32224 USA
[2] EPI Q Inc, Oak Brook, IL USA
[3] Med Data Analyt, Parsippany, NJ USA
[4] Merck Co Inc, Kenilworth, NJ USA
[5] Merck & Co Inc, North Wales, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.9571
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9571
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A novel drug to treat advanced melanoma.
    Meng, Lingbin
    Xu, Xiaochun
    Xin, Ying
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [22] Patterns of pharmaceutical therapy in advanced melanoma.
    Bilitou, Aikaterini
    Zhao, Zhongyun
    Barber, Beth L.
    Clapton, Genevieve Sian
    Saltman, Deborah
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [23] Immunosensitivity and resistance in advanced uveal melanoma.
    Carvajal, Richard D.
    [J]. CANCER RESEARCH, 2020, 80 (19) : 20 - 21
  • [24] Multicentre retrospective assessment of toxicity and response to immunotherapy in elderly patients with metastatic melanoma.
    Pathmanathan, Shivanshan
    Babu, Hari S.
    Mason, Robert
    Htut, Saw
    Otty, Zulfiquer Ali
    Lyle, Megan
    Dzienis, Marcin Radoslaw
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [25] Factors associated with the occurrence of myocardial infarction in patients treated for melanoma.
    Pan, Xianying
    Verma, Devashish
    Zhang, Jiayin
    Zhang, Yifan
    Ma, Xiaomei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [26] Retrospective analysis of safety and efficacy of ipilimumab in elderly patients with advanced melanoma.
    Shaw, Andrew Cota
    VanAnh Trinh
    Bassett, Roland L.
    Glitza, Isabella Claudia
    Diab, Adi
    Amaria, Rodabe Navroze
    Tawbi, Hussein Abdul-Hassan
    Davies, Michael A.
    Hwu, Wen-Jen
    Hwu, Patrick
    Patel, Sapna Pradyuman
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [27] Use of a lentiviral flap vector for induction of CTL immunity against melanoma. Perspectives for immunotherapy
    Firat, H
    Zennou, V
    Garcia-Pons, F
    Ginhoux, F
    Cochet, M
    Danos, O
    Lemonnier, FA
    Langlade-Demoyen, P
    [J]. JOURNAL OF GENE MEDICINE, 2002, 4 (01): : 38 - 45
  • [28] Single-center experience with ipilimumab in patients with pretreated advanced melanoma.
    Wilgenhof, Sofie
    Seghers, Amelie Clementine
    Du Four, Stephanie
    Lienard, Danielle
    Salmon, Isabelle
    Del Marmol, Veronique
    Neyns, Bart
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [29] Immunotherapy for Advanced Melanoma
    Fang, Lei
    Lonsdorf, Anke S.
    Hwang, Sam T.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 (11) : 2596 - 2605
  • [30] Mechanisms of elevated serum creatinine in patients receiving vemurafenib for advanced melanoma.
    Hurabielle, Charlotte
    Pillebout, Evangeline
    Stehle, Thomas
    Pages, Cecile
    Roux, Jennifer
    Schneider, Pierre
    Chevret, Sylvie
    Mourah, Samia
    Basset-Seguin, Nicole
    Chaffaut, Cendrine
    Vidal-Petiot, Emmanuelle
    Flamant, Martin
    Lebbe, Celeste
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345